Comparative effects of denosumab or bisphosphonate treatment on bone mineral density and calcium metabolism in postmenopausal women.

J Musculoskelet Neuronal Interact · 2017 · PMC5383772 · PMID 28250248

Europe PMC

hedged sentence

0.1540

closest p · 3.1× alpha

0.1540

boldest claim

The sentences

did not reach statistical significancep=0.154not close (p > 0.1)

The same was apparent for lumbar spine BMD, the difference, however, did not reach statistical significance (denosumab 9.03%±11.3, bisphosphonates 4.5%±11.6, p=0.154).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.